Therapeutic Asset Ratings

1,133 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
kl002 Parkinson Disease	Second Affiliated Hospital, School of Medicine, Zhejiang University	Early P1	NR ()
L Carnitine Systemic Primary Carnitine Deficiency Disease	Ain Shams University	Early P1	NR ()
Lvivo-Tavec400 Product Immunoglobulin G4-Related Sclerosing Disease	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early P1	NR ()
Lvivo-Tavec400 Product Myasthenia Gravis	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early P1	NR ()
Lvivo-Tavec400 Product Systemic Lupus Erythematosus	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early P1	NR ()
Metabolically Armed Egfrviii Car-T Cells Glioblastoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	Early P1	NR ()
Metabolically Armed Gpc3 Car-T Cells Hepatocellular Carcinoma	Zhejiang University	Early P1	NR ()
Miyairi 588 Bowel Dysfunction	Huashan Hospital	Early P1	NR ()
Miyairi 588 Infectious Disease	Huashan Hospital	Early P1	NR ()
Nicotinamide Ribonucleoside Alzheimer Disease	Mclean Hospital	Early P1	NR ()
Ntx-253 Schizophrenia	Neurosterix	Early P1	NR ()
Panitumumab-Irdye800 Pituitary Gland Adenoma	Eben Rosenthal	Early P1	NR ()
Patisiran Wild Type ATTR Amyloidosis	Austin Neuromuscular Center	Early P1	NR ()
qi-019a Plasma Cell Myeloma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early P1	NR ()
qi-019b Plasma Cell Myeloma	Institute of Hematology & Blood Diseases Hospital, China	Early P1	NR ()
QL706 Rectal Carcinoma	Changhai Hospital	Early P1	NR ()
R130 Bronchus Cancer	Shanghai Yunying Medical Technology	Early P1	NR ()
Rag-21 Amyotrophic Lateral Sclerosis	Beijing Tiantan Hospital	Early P1	NR ()
Rd-Iit-001 Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	Early P1	NR ()
Regend007 Cell Therapy Idiopathic Pulmonary Fibrosis	Regend Therapeutics	Early P1	NR ()
rn9101 Plasma Cell Myeloma	The First Affiliated Hospital with Nanjing Medical University	Early P1	NR ()
Sapdm275 Tumor Vaccine Malignant Pancreatic Neoplasm	The Third Xiangya Hospital of Central South University	Early P1	NR ()
sl4903 autologous t-cell Plasma Cell Myeloma	Institute of Hematology & Blood Diseases Hospital, China	Early P1	NR ()
sp-3164 Non-Hodgkin Lymphoma	Salarius Pharmaceuticals, LLC	Early P1	NR ()
Str-P004 Non-Hodgkin Lymphoma	Starna Therapeutics	Early P1	NR ()

Showing 1101 to 1125 of 1,133 assets

PreviousPage 45 of 46Next